MOESM1 of Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study
收藏DataCite Commons2020-08-26 更新2024-07-27 收录
下载链接：
https://springernature.figshare.com/articles/MOESM1_of_Effects_of_the_Toll-like_receptor_7_TLR7_agonist_AZD8848_on_allergen-induced_responses_in_patients_with_mild_asthma_a_double-blind_randomised_parallel-group_study/11414823
下载链接
链接失效反馈官方服务：
资源简介：
Additional file 1: Table S1. Treatment effect on sputum biomarkers at visit 12 which had to take place 48 to 72 h prior to Visit 13, which took place 1 week (±1 day) after the last dose. Figure S1. Consort flow diagram. Figure S2. Sputum cytokine levels measured pre- and post-allergen challenge before and after dosing with intranasal AZD8848 or placebo. (n = 12–19 for the various biomarker analyses). Figure S3. Individual AZD8848 concentration data
附加文件1：表S1。访视12时的痰液生物标志物治疗效应，该访视需在访视13前48至72小时开展，而访视13定于末次给药后1周（±1天）进行。图S1：CONSORT流程图（Consort flow diagram）。图S2：经鼻给予AZD8848或安慰剂前后，以及过敏原激发试验前后的痰液细胞因子水平（各项生物标志物分析的样本量为12~19）。图S3：AZD8848个体浓度数据
提供机构：
figshare
创建时间：
2019-12-20
